Abstract

Objective To explore the clinical curative effect of transurethral enucleation of the prostate urethra wall and transurethral resection of prostate for therapy of benign prostatic hyperplasia (BPH) . Methods Eighty-four patients with BPH admitted to hospital from February 2014 to July 2015 were divided into control group (n=42) and study group (n=42) according to the different operation methods. The control group underwent transurethral resection of the prostate; study group underwent transurethral enucleation of the prostate anterior urethra. The operation, maximum urinary flow rate (Qmax) before and after operation, international prostate symptom score (IPSS), residual urine volume (PVR) changes, and complications of the two groups were compared. Results In the study group, the amount of bleeding, the indwelling time of catheter, the irrigation time and hospitalization time were significantly less than that of the control group, the differences were statistically significant (P 0.05). The indexes in the study group were significantly better than those in the control group, the differences were statistically significant (P<0.05); The incidence rate of complication in the study group (7.14%) was much lower than that in the control group (30.94%), and the difference was statistically significant (P<0.05). Conclusions Transurethral enucleation of the prostate urethra wall in the treatment of benign prostatic hyperplasia is significantly superior to that of transurethral resection of the prostate, and it can reduce the operation time and amount of bleeding, promote the recovery of postoperative body function, and it has less incidence of complications and high safety, with safety. Key words: Transurethral enucleation of the prostate urethra wall; Transurethral resection of prostate; Benign prostatic hyperplasia

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call